MISSION
The Pharmacy Addictions Research & Medicine (PhARM) Program addresses systemic barriers, inequities, and stigma related to evidence-based substance use disorder treatment and harm reduction interventions by conducting innovative research and providing education and resources informed by people with lived experience to health professionals, paraprofessionals, academics, and community members.
educational programs
Meet The Team
FACULTY & STAFF
Tyler Varisco, PharmD, PhD
Director
Molly Nichols, PharmD, MS
Research Fellow
Lindsey Loera, PharmD
Associate Director
Daniel Sledge, LP
Academic Detailer
.jpeg)
Jennifer Bosworth, PharmD
Project Director
Carlos Tirado, MD, MPH
Medical Consultant
Mona Keshavarzi, BA
Research Program Coordinator - Events
Jenny Carrasco, MA
Program & Communications Manager
TRAINEES
_edited.jpg)
Claire Zagorski, MSc, LP
Graduate Research Assistant
Abolfazl Sadeghi, PharmD, HTA, MSc
Graduate Research Assistant
Parasto Mousavi, PharmD
Graduate Research Assistant
Brittany Herman
P3 Research Assistant
Marissa Johnson
P3 Research Assistant
_edited_edited.jpg)
Delandra Robinson
P4 Trainee
_edited.jpg)
Sydney Saenz
P4 Trainee
We're pleased to share that Dr. Tyler Varisco has officially joined us as the new Director of the PhARM Program!
Dr. Varisco is a registered pharmacist and trained health services researcher whose work focuses on improving the quality of care for people with a substance use disorder. He earned his Doctor of Pharmacy from The University of Texas at Austin College of Pharmacy and his Ph.D. in Pharmaceutical Health Outcomes and Policy from the University of Houston College of Pharmacy.
Throughout his career, Dr. Varisco has led impactful, collaborative efforts to expand access to treatment. He played a key role in developing the Pharmacy Access to Resources and Medication for OUD Practice Guideline, and currently serves as a subject matter expert for SAMHSA’s revision of Treatment Improvement Protocol 63, which guides the use of medications for opioid use disorder across the country. His research continues to shape how policy influences both patient and provider experiences in behavioral health and addiction care.
We’re excited to welcome Dr. Varisco into this leadership role and look forward to the expertise and vision he brings to the PhARM Program.